Contrast Volume and Renal Risk in a Patient With CKD and a Borderline Ejection Fraction
A 70-year-old man with chronic kidney disease (eGFR 28 mL/min/1.73 m²) and an ejection fraction of 35% is scheduled for coronary angiography and possible PCI. He weighs 95 kg and has a history of heart failure. The lab has iso-osmolar and low-osmolar contrast available. The operator plans a diagnostic study and, if a lesion is found, ad hoc PCI. The patient's baseline creatinine is 2.4 mg/dL, and he is not on dialysis. The team must plan contrast use and periprocedural care to minimize acute kidney injury and volume overload.
1. How should the team plan contrast volume and choice to reduce the risk of contrast-induced acute kidney injury?
Read the worked answer
Use a risk-stratified contrast strategy: calculate the maximum allowable contrast volume using a validated formula (e.g., Cigarroa formula: 5 × body weight (kg) × serum creatinine (mg/dL) / baseline creatinine, or the more commonly used ratio of contrast volume to creatinine clearance). For this patient, the allowable volume is limited; aim for the lowest volume that answers the clinical question. Choose low-osmolar or iso-osmolar contrast per institutional protocol; there is no strong evidence that one is superior in all patients, but avoid high-osmolar agents. Techniques to reduce volume: biplane imaging, fluoroscopy storage and review rather than repeat runs, limiting cine runs, using IVUS or physiology to avoid unnecessary PCI, and staging the procedure if PCI is needed. Ensure adequate hydration, avoid nephrotoxins, and consider bicarbonate or saline hydration per protocol. If the diagnostic study shows a lesion, consider deferring PCI to a separate session to reduce total contrast load.
2. What are the priorities for periprocedural volume management in a patient with EF 35% and CKD?
Read the worked answer
Balance two competing risks: contrast-induced AKI (favoring hydration) and volume overload (favoring restriction in a patient with reduced EF). Priorities: (1) assess volume status clinically (JVP, edema, lung exam) and with echocardiography if needed; (2) use isotonic saline at a modest rate rather than large boluses, and monitor for pulmonary congestion; (3) avoid routine sodium bicarbonate if it would add volume without clear benefit - follow institutional protocol; (4) monitor urine output and daily weights; (5) continue guideline-directed heart failure medications as tolerated, but hold nephrotoxins (NSAIDs, aminoglycosides); (6) if PCI is performed, use minimal contrast and consider IVUS guidance to reduce contrast. Post-procedure, monitor creatinine at 48–72 hours and watch for oliguria or worsening heart failure.
3. The patient develops oliguria and rising creatinine 48 hours after the procedure. What is the differential and initial management?
Read the worked answer
Consider contrast-induced AKI, atheroembolic renal disease (especially if catheter manipulation was extensive), volume depletion or overload, medication effect (e.g., ACE inhibitors, diuretics, NSAIDs), and urinary obstruction. Initial management: (1) review medications and hold nephrotoxins; (2) assess volume status and adjust fluids/diuretics accordingly; (3) check urinalysis, renal ultrasound if obstruction is suspected, and eosinophils/ESR if atheroembolism is considered; (4) avoid further contrast; (5) monitor electrolytes and acid-base status; (6) involve nephrology early if creatinine continues to rise or oliguria persists. The key is to distinguish contrast-induced AKI (often recovers) from atheroembolic disease (often progressive and requires supportive care) and to avoid additional renal insults.